The DMKN gene, which harbors five splice variants (α, β, γ, δ, and ε), has been previously studied to suggest that suppressing DMKN-β/γ reduces the invasiveness and migratory capabilities of pancreatic cancer cells, potentially impacting the epithelial-mesenchymal transformation (EMT). Here, DMKN is linked to familial pancreatic carcinoma.